Trial Profile
Administration of concentrated Protein C in patients with severe sepsis and contraindications to activated protein C. A monocentric, randomised placebo-controlled study. [Somministrazione di concentrato di Proteina C in pazienti con sepsi severa e controindicazioni alla Proteina C attivata. Uno studio monocentrico, randomizzato controllato con placebo.]
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 25 Oct 2012
Price :
$35
*
At a glance
- Drugs Protein C (Primary)
- Indications Disseminated intravascular coagulation; Embolism and thrombosis; Sepsis
- Focus Biomarker; Therapeutic Use
- 25 Oct 2012 New trial record